Sparsentan is Used for slowing the progression of primary immunoglobulin A nephropathy (IgAN) in adults at risk of rapid disease progression. It was first introduced by Travere Therapeutics Inc in its drug Filspari on Feb 17, 2023.

Sparsentan Patents

Given below is the list of patents protecting Sparsentan, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in	Drug Patent Number	Drug Patent Title	Drug Patent Expiry	Drug Owner
Filspari	US9993461	Method for treating disorders associated with glomerular function	Mar 29, 2030	Travere

Add above patents to watchlist

Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳